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Abstract VacA, the vacuolating cytotoxin secreted by Helico-
bacter pylori, is believed to be a major causative factor in the
development of gastroduodenal ulcers. This toxin causes
vacuolation of cultured cells and it has recently been found to
form anion-selective channels upon insertion into planar bilayers
as well as in the plasmamembrane of HeLa cells. Here, we
identify a series of inhibitors of VacA channels and we compare
their effectiveness as channel blockers and as inhibitors of VacA-
induced vacuolation, confirming that the two phenomena are
linked. This characterization opens the way to studies in other
experimental systems and to the search for a specific inhibitor of
VacA action.
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1. Introduction
Infection by Helicobacter pylori is at the origin of most
cases of gastritis and gastric ulcers in humans [1,2]. Among
the virulence factors produced by the pathogenic strains of the
bacterium, CagA and VacA appear to be the most important
[3]. The latter is a secreted and partially bacterium surface-
bound [4] protein with a mass of about 95 kDa in its mature
form, comprising N-terminal (p37) and C-terminal (p58) do-
mains [5,6]. The secreted monomers assemble to form hexam-
ers and heptamers, which at neutral pH may further associate
to form dodecamers and tetradecamers [7^9]. Exposure of the
isolated toxin to acidic conditions (pH6 5) leads to structural
alterations, with dissociation of the complex into monomers
[8^11]. Low pH exposure strongly increases the insertion of
VacA into membranes [11] as well as its ability to induce the
formation of vacuoles in cells incubated in media containing
membrane-permeant amines [10]. The vacuoles originate from
late endosomal/lysosomal compartments [12^14].
The mechanism of VacA-induced vacuolization has not yet
been established, but the process presumably involves inter-
nalized toxin, since vacuoles develop following expression of
the toxin in the cell cytosol [15,16]. VacA is known to be
slowly endocytosed after binding to the plasmamembrane
and to be localized intracellularly in the endosome-derived
acidic compartments [17]. Recently, VacA has been reported
to form anion-selective, low-conductance, voltage-dependent
channels in planar membranes [18,19] and in the plasmamem-
brane of HeLa cells exposed to the toxin [20]. The pore-form-
ing activity of the toxin is greatly enhanced in acidic media or
if the toxin is pre-activated by exposure to low pH. Channel
formation is probably due to hexameric complexes, which re-
form from the monomers prevailing at acidic pH [9,19].
It is thus important to identify and characterize inhibitors
of the channel-forming and vacuolating activities of the toxin,
aiming at (i) a better understanding of the properties of this
novel channel, (ii) providing further evidence of the correla-
tion between channel activity and vacuolization, (iii) identify-
ing molecules which may be of potential value as toxin-spe-
ci¢c inhibitors.
2. Materials and methods
2.1. Toxin and reagents
VacA was puri¢ed from H. pylori CCUG 17874 as described [21].
All planar bilayer experiments reported were performed using syn-
thetic diphytanoyl-phosphatidylcholine (Avanti Polar Lipids, Alabast-
er, AL, USA; puritys 99%) as the membrane lipid. R(+)-2-((2-cyclo-
pentenyl-6,7-dichloro-2,3-dihydro-2-methyl-1-oxo-1H-inden-5-yl)oxy)-
acetic acid (IAA-94) and 5-nitro-2-(3-phenylpropylamino) benzoic
acid (NPPB) were purchased from Research Biochemicals Interna-
tional (Natick, MA, USA). N-phenylanthranilic acid (NPA), 2-(3-(tri-
£uoromethyl)anilino)benzoic acid (£ufenamic acid), 2-(3-(tri£uorome-
thyl)anilino)nicotinic acid (ni£umic acid), acetylsalicylic acid, 4,4P-
diisothiocyanatostilbene-2,2P-disulfonic acid (disodium salt) (DIDS),
4-acetamido-4P-isothiocyanatostilbene-2,2P-disulfonic acid (disodium
salt) (SITS) and N-p-(2-(5-chloro-2-methoxybenzamido)ethyl)ben-
zene-sulfonyl-NP-cyclohexylurea (glibenclamide) were from Sigma
(Milan, Italy). All the compounds listed, with the exception of acetyl-
salicylic acid, are known inhibitors of chloride channels. They were
used as 25, 50 or 100 mM stock solutions in DMSO, except for DIDS
and SITS, which were dissolved in water, and acetylsalicylic acid in
ethanol.
2.2. Planar lipid bilayer experiments
Experiments were carried out as already described [18]. The cis
compartment is de¢ned as the one into which the toxin was added,
which was also the one containing the active electrode, whose voltage
relative to ground (in trans) is reported. Current (cations) £owing
from the cis to the trans side was considered positive and plotted
upward. The standard medium used was 0.5 M KCl, 0.5 mM CaCl2,
0.5 mM MgCl2, 10 mM HEPES/K, pH 7.2, in both chambers. In all
cases, VacA was pre-activated by incubation in phosphate-bu¡ered
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saline (PBS)-HCl, pH 2, at 37‡C for 8 min, immediately before use.
We have observed that the process of pore formation is accelerated at
alkaline medium pH values. In part of the experiments therefore, after
VacA addition, the pH of the bilayer chambers was shifted to 7.5 with
KOH and re-adjusted to 7.2 with HCl after a sizable current had
developed. Inhibitors were added to the same compartment into
which the toxin was introduced, as a few Wl of stock solution, after
the current had reached a nearly stable level. In some cases, the
measured current levels were corrected for a residual incorporation
of VacA channels during the experiment as described in [18].
2.3. Patch-clamp experiments
HeLa cells were cultured at 37‡C in plastic £asks in DMEM, sup-
plemented with 10% (v/v) FCS and gentamicin (50 Wg/ml) in a 5%
CO2 humidi¢ed atmosphere. They were detached by trypsin-EDTA
treatment, re-seeded (20^30 000 cells/cm2) and grown for 2 days on
glass coverslips in six-well plates. Immediately before the experiment,
the cells were treated at 37‡C for 30 min with 0.5 Wg/ml acid-activated
VacA diluted in DMEM and subsequently washed with the bath
solution (150 mM NaCl, 5 mM KCl, 2.5 mM CaCl2, 1 mM MgCl2,
10 mM HEPES, pH 7.3^7.4). The pipette contained 134 mM KCl,
2 mM MgCl2, 1 mM CaCl2, 10 mM EGTA, 10 mM HEPES, pH 7.35
(10 nM free Ca2). Whole-cell currents were monitored with an EPC-
7 ampli¢er (List) and pulse protocols were applied using the Pclamp6
program set (Axon). Capacitive currents were partially cancelled man-
ually and series resistance was compensated when necessary. Anionic
inward £uxes are plotted as outward currents. Membrane potentials
are reported as intracellular with respect to ground, i.e. as pipette
potentials, equivalent to the potential in the trans compartment of
bilayer experiments. In most experiments, the membrane potential
was clamped at 380 mV and 300 ms pulses were applied in 20 mV
steps from 380 to +80 mV, with 40 or 10 s intervals between pulses.
Addition of the inhibitors was performed manually with a micropi-
pette, followed by thorough mixing of the chamber contents (0.5 ml)
by withdrawal and re-addition of 300 Wl aliquots.
2.4. Quanti¢cation of vacuolation
Vacuole formation in cultured HeLa cells was determined by the
neutral red uptake assay [22], as described [18]. To induce vacuoliza-
tion, after overnight culture, the cells were incubated for 3 h at 37‡C
with 5 Wg/ml acid-activated VacA plus 5 mM NH4Cl, with or without
inhibitors. The cells were then washed with PBS plus 0.3% (w/v)
bovine serum albumin (BSA) and further incubated for 8 min at
room temperature with 8 mM neutral red in PBS plus 5 mM NH4Cl
and 0.3% BSA. After three washes with the same medium, the dye
was extracted with 70% (v/v) ethanol/0.37% (v/v) hydrochloric acid
and quanti¢ed by determining the absorbance at 405 nm.
3. Results
3.1. Chloride channel inhibitors reduce current conduction and
cell vacuolization by VacA with the same order of potency
Since VacA pores are anion-selective, we tested known in-
hibitors of chloride channels. They included four arylamino-
benzoates related to diphenylamine-2-carboxylate, the indanyl
alkanoic acid IAA-94 and the two stilbene sulfonate deriva-
tives SITS and DIDS. Their e¡ect on VacA-mediated current
conduction was determined in planar bilayer experiments.
Fig. 1 illustrates data collection and the e¡ects of NPPB
and N-phenyl anthranilic acid. The current decreased rapidly
upon stirring the contents of the chamber into which the in-
hibitor was added (cis side). The data obtained are summar-
ized in Fig. 2, which presents titrations of current conduction
in bilayer experiments. The data are ¢tted by curves described
by the relationship %r:c: = 1003P1/(1+KD/[L]), a form of the
Langmuir isotherm, in which %r:c: stands for the % residual
current, [L] is the concentration of inhibitor and P1 is a ¢tting
parameter, whose physical meaning is the maximal percentage
of inhibition theoretically observable at an in¢nite concentra-
tion of inhibitor. The values of the parameters KD and P1 are
listed in Table 1. It is noteworthy that for three of the aryl-
aminobenzoates and IAA-94, P1 is signi¢cantly lower than
100, leading to the prediction that current conduction would
not be completely inhibited even at in¢nite concentration of
Fig. 1. Current records exemplifying measurements of inhibition of
current conduction by VacA in planar bilayer experiments. NPPB
(A) or NPA (B) were added at the indicated ¢nal concentration to
the cis chamber. Inhibition took place upon stirring of the chamber
contents. The disturbances caused by stirring have been partly elimi-
nated for clarity. The origin of the time scale has been arbitrarily
positioned at a moment following the attainment of a stable current
level. Filtering: 10 Hz. Digital sampling: 50 Hz.
Table 1
Tabulation of KD, IC50 and P1 values
Inhibitor KD þ S.D. (WM) IC50 (WM)a P1 þ S.D.
NPPB 18 þ 2 24 88 þ 2
DIDS 36 þ 2 40 95 þ 2
Flufenamic acid 39 þ 5 57 84 þ 3
Ni£umic acid 74 þ 16 99 87 þ 6
NPA 139 þ 27 134 102 þ 8
SITS 149 þ 19 156 98 þ 5
R(+)-IAA-94 190 þ 21 469 70 þ 4
aCalculated from the ¢tting equation.
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the inhibitor. From the KD values, the following ranking of
inhibitor potency (at low concentrations) can be derived:
NPPBsDIDSw£ufenamic acids ni£umic acidsNPAw
SITSs IAA-94.
This sequence can be used to distinguish VacA from
other anion channels. For example, Ca2-activated chloride
channels are inhibited with the order: ni£umic acids
NPPBsNPAwDIDS [23]. In the case of glibenclamide,
only low concentrations were used because of the solubility
characteristics of this compound and a KD value could not be
determined. Current conduction was reduced to 84.6 þ 0.3%
( þ S.E.M., n = 4) and 71.8 þ 1.9% (n = 5) of control values
with 20 and 50 WM, respectively. Glibenclamide thus appears
to be about as e¡ective as NPA and SITS. Acetylsalicylic acid
(aspirin), which has some structural resemblance to the fena-
mates used in this work, had no e¡ect on either current con-
duction or vacuolation (not shown).
Fig. 3 presents a comparison of the inhibition of VacA-
mediated current conduction exerted by ¢ve of the com-
pounds in patch-clamp experiments on toxin-exposed HeLa
cells and in planar lipid bilayer determinations.
It has previously been suggested that the VacA anion-selec-
tive channel plays a major role in vacuole formation and that
the major sites of this action are late endosomal and lysoso-
mal compartments [18]. If this is the case and if the various
inhibitors have comparable membrane permeability proper-
ties, the VacA channel inhibitors identi¢ed here should (a)
inhibit VacA-induced vacuolization measured quantitatively
as neutral red uptake and (b) follow the same order of po-
tency determined for their inhibition of current £ow through
the channel. Fig. 4 shows that this is indeed the case. With
glibenclamide, neutral red uptake was reduced to 85.6 þ 3.2%
and 73.8 þ 3.5% (n = 5) of control with 20 and 50 WM inhib-
itor, in agreement with the bilayer data (see above). DIDS and
SITS were not tested as inhibitors of vacuolation, because
Fig. 2. Titration curves plotting the residual current vs. the concentration of the indicated inhibitors in the cis compartment. Each experimental
point represents the average of 3^11 independent determinations, þ S.E.M. The voltage applied was 340 mV. Curves: 1 (E) NPPB; 2 (b) £ufe-
namic acid; 3 (O) ni£umic acid; 4 (8) N-phenylanthranilic acid; 5 (F) DIDS; 6 (a) SITS; 7 (R) IAA-94; (7) glibenclamide.
C
Fig. 3. Inhibition of VacA-induced whole-cell currents and compari-
son with bilayer data. A and B: Exemplary current traces recorded
from the same cell before (A) and after (B) the addition of 100 WM
ni£umic acid to the bath. C: A comparison of the inhibition by the
speci¢ed compounds (100 WM) in patch-clamp (P) and bilayer (B)
experiments. Applied voltage: 340 mV (bilayer, cis compartment),
+40 mV (patch-clamp, pipette; +50 for NPPB and IAA-94). Aver-
ages þ S.E.M. The number of independent experiments averaged is
indicated in the ¢gure.
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these compounds are well known to covalently and unspeci¢-
cally modify proteins over the long incubation times needed to
assess e¡ects on vacuolation.
4. Discussion
The results reported here show that VacA channels are in-
hibited by a number of known chloride channel inhibitors.
The agreement between the data obtained with patch-clamp
and those derived from experiments with planar lipid bilayers
(Fig. 3) provides additional evidence that the increased per-
meability of the plasma membrane of HeLa cells exposed to
the activated toxin [20] is due to the insertion of VacA chan-
nels and not due to possible activating e¡ects on endogenous
chloride channels.
In the absence of detailed structural information on the
VacA channel, it is di⁄cult to rationalize the scale of potency
of the inhibitors determined here in terms of the structures of
the compounds. Most of the inhibitors we used are generally
considered to be chloride channel blockers (e.g. [24^27]). Since
most of the compounds tested here inhibit a variety of anion-
selective channels besides VacA, which has no identi¢able
homology with known channels, it may be assumed that the
block results from charge/dipole and hydrophobic interactions
in the lumen of the channel, without the involvement of a
binding site with a conserved structure. A di¡erent mechanism
may apply in the case of glibenclamide, an uncharged (but
dipole-rich) molecule mainly known as an inhibitor of KATP
channels.
A major conclusion that can be drawn at the present stage
is that a strict correlation exists between VacA channel activ-
ity and the major recognized e¡ect of VacA at the cellular
level, namely vacuole induction. All the six inhibitors of the
channel tested also inhibited vacuolation. It is noteworthy in
this context that acetylsalicylic acid was completely ine¡ective
on either current conduction or vacuolation. This lack of ac-
tivity, which might be related to its smaller size and/or lack of
an apolar moiety, indicates that the inhibition of vacuolation
by arylaminobenzoates, which are non-steroidal anti-in£am-
matory drugs and cyclooxygenase inhibitors (e.g. [28]), is not
a consequence of the inhibition of cyclooxygenase, which is
inhibited also by acetylsalicylate.
The fact that the compounds used exhibited the same e¡ec-
tiveness ranking as inhibitors of current conduction and as
inhibitors of vacuolization is highly signi¢cant. We have al-
ready shown that another inhibitor of vacuolization, the his-
tidine reagent DEPC, also inhibits current conduction and
that the p58 domain of VacA is incapable of either forming
channels or inducing vacuoles [18]. Furthermore, both pore
formation and vacuolation are strongly increased upon expo-
sure of the toxin to low pH. Taken together, these data lead
to the conclusion that VacA channel activity and vacuole in-
duction are inseparable. The facts that VacA ends up in the
endosomal-vacuolar membrane [17] and that the pH of these
compartments is acidic suggest that vacuolation may be a
consequence of channel formation in the endosomal mem-
brane. This hypothesis is consistent with the ability of VacA
synthesized in the cytoplasm to cause vacuoles [15,16] if it is
assumed that the toxin can enter this membrane directly from
the cytoplasm and not only by endocytosis. This seems pos-
sible, given the demonstrated ability of VacA to form chan-
nels in arti¢cial membranes, irrespective of their composition
[18]. This suggestion is also in keeping with the evidence that
the activating e¡ect of low pH is due to the dissociation of
oligomers into monomers [8,11], which would be the species
capable of membrane insertion (alternatively, the hexamer
might insert) [9]. Expression of VacA in the cytoplasm pre-
sumably results in the production of monomers, which might
insert into the endosomal (and possibly other) membranes in a
process competing with oligomerization to yield the ‘unpro-
ductive’ dodecamer. Once there, the toxin is expected to in-
crease the membrane permeability to chloride and bicarbon-
ate, causing depolarization, increased activity by the V-
ATPase, accumulation of ammonium ions inside the vacuoles,
increase of the osmotic pressure in these compartments, water
in£ux and swelling [6,18,19]. If an adequate supply of mem-
brane is assured by Rab7-dependent [14] fusion, the ¢nal out-
come of the process would be the formation of large vacuoles.
In conclusion, the quantitative characterization of VacA
inhibition by a spectrum of compounds presented above
opens the way to the identi¢cation and the study of this
channel and of the e¡ects of its activity in systems more phys-
iologically relevant than planar bilayers, such as gastric epith-
elia or animal models. This pharmacological characterization
may serve as a starting point for a search for speci¢c inhib-
itors, potentially useful in cases of antibiotic-resistant infec-
tion. Furthermore, the establishment of a correlation between
channel formation and cytotoxicity by VacA o¡ers a method
to screen VacA-derived constructs in vitro to select the ones
most promising for the formulation of an anti-H. pylori vac-
cine.
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